PIN1 Is an E2F Target Gene Essential for Neu/Ras-Induced Transformation of Mammary Epithelial Cells

REFERENCES

• Albanese, C., J. Johnson, G. Watanabe, N. Eklund, D. Vu, A. Arnold, and R. G. Pestell. 1995. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270: 23589–23597.
   PubMed Web of Science ®Google Scholar
• Alt, J. R., J. L. Cleveland, M. Hannink, and J. A. Diehl. 2000. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev. 14: 3102–3114.
   PubMed Web of Science ®Google Scholar
• Andrechek, E. R., and W. J. Muller. 2000. Tyrosine kinase signalling in breast cancer: tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer. Breast Cancer Res. 2: 211–216.
   PubMedGoogle Scholar
• Arber, N., Y. Doki, E. K. Han, A. Sgambato, P. Zhou, N. H. Kim, T. Delohery, M. G. Klein, P. R. Holt, and I. B. Weinstein. 1997. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res. 57: 1569–1574.
   PubMed Web of Science ®Google Scholar
• Bartkova, J., J. Lukas, H. Muller, D. Lutzhoft, M. Strauss, and J. Bartek. 1994. Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer 57: 353–361.
   PubMed Web of Science ®Google Scholar
• Blume-Jensen, P., and T. Hunter. 2001. Oncogenic kinase signalling. Nature 411: 355–365.
   PubMed Web of Science ®Google Scholar
• Chou, J. L., Z. Fan, T. DeBlasio, A. Koff, N. Rosen, and J. Mendelsohn. 1999. Constitutive overexpression of cyclin D1 in human breast epithelial cells does not prevent G1 arrest induced by deprivation of epidermal growth factor. Breast Cancer Res. Treat. 55: 267–283.
   Google Scholar
• Ciardiello, F., M. Gottardis, F. Basolo, S. Pepe, N. Normanno, R. B. Dickson, A. R. Bianco, and D. S. Salomon. 1992. Additive effects of c-erbB-2, c-Ha-Ras, and transforming growth factor-alpha genes on in vitro transformation of human mammary epithelial cells. Mol. Carcinog. 6: 43–52.
   PubMedGoogle Scholar
• Diehl, J. A., M. Cheng, M. F. Roussel, and C. J. Sherr. 1998. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12: 3499–3511.
   PubMed Web of Science ®Google Scholar
• Diehl, J. A., F. Zindy, and C. J. Sherr. 1997. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11: 957–972.
   PubMed Web of Science ®Google Scholar
• Driscoll, B., L. Wu, S. Buckley, F. L. Hall, K. D. Anderson, and D. Warburton. 1997. Cyclin D1 antisense RNA destabilizes pRb and retards lung cancer cell growth. Am. J. Physiol. 273: L941–949.
   PubMedGoogle Scholar
• Fan, J., and J. R. Bertino. 1997. K-Ras modulates the cell cycle via both positive and negative regulatory pathways. Oncogene 14: 2595–2607.
   PubMed Web of Science ®Google Scholar
• Fantl, V., G. Stamp, A. Andrews, I. Rosewell, and C. Dickson. 1995. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9: 2364–2372.
   PubMed Web of Science ®Google Scholar
• Fry, C. J., J. E. Slansky, and P. J. Farnham. 1997. Position-dependent transcriptional regulation of the murine dihydrofolate reductase promoter by the E2F transactivation domain. Mol. Cell. Biol. 17: 1966–1976.
   PubMedGoogle Scholar
• Gillett, C., V. Fantl, R. Smith, C. Fisher, J. Bartek, C. Dickson, D. Barnes, and G. Peters. 1994. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 54: 1812–1817.
   PubMed Web of Science ®Google Scholar
• Giunciuglio, D., M. Culty, G. Fassina, L. Masiello, A. Melchiori, G. Paglialunga, G. Arand, F. Ciardiello, F. Basolo, E. W. Thompson, et al. 1995. Invasive phenotype of MCF10A cells overexpressing c-Ha-Ras and c-erbB-2 oncogenes. Int. J. Cancer 63: 815–822.
   PubMedGoogle Scholar
• Guttridge, D. C., C. Albanese, J. Y. Reuther, R. G. Pestell, and A. S. Baldwin, Jr. 1999. NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19: 5785–5799.
   PubMed Web of Science ®Google Scholar
• Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100: 57–70.
   PubMed Web of Science ®Google Scholar
• Harari, D., and Y. Yarden. 2000. Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. Oncogene 19: 6102–6114.
   PubMed Web of Science ®Google Scholar
• Hinds, P. W., S. F. Dowdy, E. N. Eaton, A. Arnold, and R. A. Weinberg. 1994. Function of a human cyclin gene as an oncogene. Proc. Natl. Acad. Sci. USA 91: 709–713.
   PubMed Web of Science ®Google Scholar
• Hsu, T., D. McRackan, T. S. Vincent, and H. Gert De Couet. 2001. Drosophila Pin1 prolyl isomerase Dodo is a MAP kinase signal responder during oogenesis. Nat. Cell Biol. 3: 538–543.
   PubMedGoogle Scholar
• Hunter, T. 1998. Prolyl isomerase and nuclear function. Cell 92: 141–143.
   PubMedGoogle Scholar
• Imai, Y., Y. Matsushima, T. Sugimura, and M. Terada. 1991. A simple and rapid method for generating a deletion by PCR. Nucleic Acids Res. 19: 2785.
   PubMedGoogle Scholar
• Johnson, D. G., J. K. Schwarz, W. D. Cress, and J. R. Nevins. 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365: 349–352.
   PubMed Web of Science ®Google Scholar
• Karlseder, J., H. Rotheneder, and E. Wintersberger. 1996. Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. Mol. Cell. Biol. 16: 1659–1667.
   PubMed Web of Science ®Google Scholar
• Kornmann, M., N. Arber, and M. Korc. 1998. Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum. J. Clin. Investig. 101: 344–352.
   PubMed Web of Science ®Google Scholar
• Lee, R. J., C. Albanese, M. Fu, M. D'Amico, B. Lin, G. Watanabe, G. K. Haines III, P. M. Siegel, M. C. Hung, Y. Yarden, J. M. Horowitz, W. J. Muller, and R. G. Pestell. 2000. Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway. Mol. Cell. Biol. 20: 672–683.
   PubMed Web of Science ®Google Scholar
• Lin, S. Y., W. Xia, J. C. Wang, K. Y. Kwong, B. Spohn, Y. Wen, R. G. Pestell, and M. C. Hung. 2000. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc. Natl. Acad. Sci. USA 97: 4262–4266.
   PubMed Web of Science ®Google Scholar
• Liou, Y. C., A. Ryo, H. K. Huang, P. J. Lu, R. Bronson, F. Fujimori, U. Uchida, T. Hunter, and K. P. Lu. 2002. Loss of Pin1 function in the mouse resembles the cyclin D1-null phenotypes. Proc. Natl. Acad. Sci. USA 99: 1335–1340.
   PubMedGoogle Scholar
• Lu, K. P., S. D. Hanes, and T. Hunter. 1996. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 380: 544–547.
   PubMed Web of Science ®Google Scholar
• Lu, K. P., Y. C. Liou, and X. Z. Zhou. 2002. Pinning down the proline-directed phosphorylation signaling. Trends Cell Biol. 12: 164–172.
   PubMed Web of Science ®Google Scholar
• Lu, P. J., G. Wulf, X. Z. Zhou, P. Davies, and K. P. Lu. 1999. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 399: 784–788.
   PubMed Web of Science ®Google Scholar
• Lu, P. J., X. Z. Zhou, Y. C. Liou, J. P. Noel, and K. P. Lu. 2002. Role of WW domain phosphorylation in regulating its phosphoserine-binding activity and the Pin1 function. J. Biol. Chem. 277: 2381–2384.
   PubMed Web of Science ®Google Scholar
• Lu, P. J., X. Z. Zhou, M. Shen, and K. P. Lu. 1999. A function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science 283: 1325–1328.
   PubMed Web of Science ®Google Scholar
• Macleod, K. 1999. pRb and E2f-1 in mouse development and tumorigenesis. Curr. Opin. Genet. Dev. 9: 31–39.
   PubMedGoogle Scholar
• Muller, W. J., E. Sinn, P. K. Pattengale, R. Wallace, and P. Leder. 1988. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-Neu oncogene. Cell 54: 105–115.
   PubMed Web of Science ®Google Scholar
• Muthuswamy, S. K., D. Li, S. Lelievre, M. J. Bissell, and J. S. Brugge. 2001. ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat. Cell Biol. 3: 785–792.
   PubMed Web of Science ®Google Scholar
• Neill, S. D., C. Hemstrom, A. Virtanen, and J. R. Nevins. 1990. An adenovirus E4 gene product trans-activates E2 transcription and stimulates stable E2F binding through a direct association with E2F. Proc. Natl. Acad. Sci. USA 87: 2008–2012.
   PubMedGoogle Scholar
• Nevins, J. R. 2001. The Rb/E2F pathway and cancer. Hum. Mol. Genet. 10: 699–703.
   PubMed Web of Science ®Google Scholar
• Ohtani, K., J. DeGregori, and J. R. Nevins. 1995. Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. USA 92: 12146–12150.
   PubMed Web of Science ®Google Scholar
• Ohtani, K., R. Iwanaga, M. Nakamura, M. Ikeda, N. Yabuta, H. Tsuruga, and H. Nojima. 1999. Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F. Oncogene 18: 2299–2309.
   PubMedGoogle Scholar
• Petersen, O. W., L. Ronnov-Jessen, A. R. Howlett, and M. J. Bissell. 1992. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc. Natl. Acad. Sci. USA 89: 9064–9068.
   PubMed Web of Science ®Google Scholar
• Ranganathan, R., K. P. Lu, T. Hunter, and J. P. Noel. 1997. Structural and functional analysis of the mitotic peptidyl-prolyl isomerase Pin1 suggests that substrate recognition is phosphorylation dependent. Cell 89: 875–886.
   PubMed Web of Science ®Google Scholar
• Ryo, A., N. Nakamura, G. Wulf, Y. C. Liou, and K. P. Lu. 2001. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat. Cell Biol. 3: 793–801.
   PubMed Web of Science ®Google Scholar
• Schrump, D. S., A. Chen, and U. Consoli. 1996. Inhibition of lung cancer proliferation by antisense cyclin D. Cancer Gene Ther. 3: 131–135.
   PubMed Web of Science ®Google Scholar
• Shen, M., P. T. Stukenberg, M. W. Kirschner, and K. P. Lu. 1998. The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins. Genes Dev. 12: 706–720.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 1996. Cancer cell cycles. Science 274: 1672–1677.
   PubMed Web of Science ®Google Scholar
• Sicinski, P., J. L. Donaher, S. B. Parker, T. Li, A. Fazeli, H. Gardner, S. Z. Haslam, R. T. Bronson, S. J. Elledge, and R. A. Weinberg. 1995. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82: 621–630.
   PubMed Web of Science ®Google Scholar
• Sinn, E., W. Muller, P. Pattengale, I. Tepler, R. Wallace, and P. Leder. 1987. Coexpression of MMTV/v-Ha-Ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 49: 465–475.
   PubMed Web of Science ®Google Scholar
• Slamon, D. J., G. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich, and W. L. McGuire. 1987. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/Neu oncogene. Science 235: 177–182.
   PubMed Web of Science ®Google Scholar
• Soule, H. D., T. M. Maloney, S. R. Wolman, W. D. Peterson, Jr., R. Brenz, C. M. McGrath, J. Russo, R. J. Pauley, R. F. Jones, and S. C. Brooks. 1990. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50: 6075–6086.
   PubMed Web of Science ®Google Scholar
• Stukenberg, P. T., and M. W. Kirschner. 2001. Pin1 acts catalytically to promote a conformational change in Cdc25. Mol. Cell 7: 1071–1083.
   PubMedGoogle Scholar
• Trimarchi, J. M., and J. A. Lees. 2002. Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell. Biol. 3: 11–20.
   PubMed Web of Science ®Google Scholar
• von Lintig, F. C., A. D. Dreilinger, N. M. Varki, A. M. Wallace, D. E. Casteel, and G. R. Boss. 2000. Ras activation in human breast cancer. Breast Cancer Res. Treat. 62: 51–62.
   Google Scholar
• Wang, T. C., R. D. Cardiff, L. Zukerberg, E. Lees, A. Arnold, and E. V. Schmidt. 1994. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369: 669–671.
   PubMed Web of Science ®Google Scholar
• Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323–330.
   PubMed Web of Science ®Google Scholar
• Wells, J., K. E. Boyd, C. J. Fry, S. M. Bartley, and P. J. Farnham. 2000. Target gene specificity of E2F and pocket protein family members in living cells. Mol. Cell. Biol. 20: 5797–5807.
   PubMed Web of Science ®Google Scholar
• Wulf, G. M., A. Ryo, G. G. Wulf, S. W. Lee, T. Niu, and K. P. Lu. 2001. Pin1 is overexpressed in breast cancer and potentiates the transcriptional activity of phosphorylated c-Jun towards the cyclin D1 gene. EMBO J. 20: 3459–3472.
   PubMed Web of Science ®Google Scholar
• Yaffe, M. B., M. Schutkowski, M. Shen, X. Z. Zhou, P. T. Stukenberg, J. Rahfeld, J. Xu, J. Kuang, M. W. Kirschner, G. Fischer, L. C. Cantley, and K. P. Lu. 1997. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 278: 1957–1960.
   PubMed Web of Science ®Google Scholar
• Yu, Q., Y. Geng, and P. Sicinski. 2001. Specific protection against breast cancers by cyclin D1 ablation. Nature 411: 1017–1021.
   PubMed Web of Science ®Google Scholar
• Zhang, S. Y., S. C. Liu, L. F. Al-Saleem, D. Holloran, J. Babb, X. Guo, and A. J. Klein-Szanto. 2000. E2F-1: a proliferative marker of breast neoplasia. Cancer Epidemiol. Biomarkers Prev. 9: 395–401.
   PubMedGoogle Scholar
• Zhou, X. Z., O. Kops, A. Werner, P. J. Lu, M. Shen, G. Stoller, G. Küllertz, M. Stark, G. Fischer, and K. P. Lu. 2000. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol. Cell 6: 873–883.
   PubMed Web of Science ®Google Scholar
• Zhou, X. Z., P. J. Lu, G. Wulf, and K. P. Lu. 1999. Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism. Cell. Mol. Life Sci. 56: 788–806.
   PubMed Web of Science ®Google Scholar